Etanercept
Etanercept, a       bioengineered soluble receptor fusion protein that blocks tumor necrosis factor       activity, is the first compound in this class to be approved for treatment of       patients with refractory rheumatoid arthritis.
 @SUBJECT$ , a       bioengineered soluble receptor fusion protein that blocks tumor necrosis factor       activity, is the first compound in this class to be approved for  @PREDICAT$  of        @OBJECT$  with refractory rheumatoid arthritis.